高级检索
中华结核和呼吸杂志
期刊首页
过刊列表
高级检索
稿件发表
• 综述 •
ENGLISH ABSTRACT
全球加速扩展结核病预防性治疗行动计划背景下的中国对策
徐彩红
赵雁林
作者及单位信息
·
DOI： 10.3760/cma.j.cn112147-20210722-00520
China′s countermeasures in the context of Global Tuberculosis Prevention Action
Xu Caihong
Zhao Yanlin
Authors Info & Affiliations
Xu Caihong
National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Zhao Yanlin
National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
·
DOI： 10.3760/cma.j.cn112147-20210722-00520
0
0
0
0
0
0
PDF下载
APP内阅读
摘要

为加速全球结核病预防性治疗扩展，世界卫生组织于2021年6月发布了全球结核病防治2.0版行动计划，要求各国政府和利益相关者积极行动，加大投资力度，扩大结核病筛查范围和发现力度，积极推进结核病预防性治疗，确保实现2018年联合国高级别会议政治宣言承诺的目标。为此，笔者结合我国结核病防治工作需要，系统梳理了开展结核病预防性治疗的必要性和紧迫性，结核病预防性治疗现状和进展，并结合全球结核病防治行动计划提出我国结核病防治的对策和建议。

ABSTRACT

In order to speed up the expansion of global tuberculosis (TB) preventive treatment (TPT), the WHO released “CALL TO ACTION 2.0 A GLOBAL DRIVE TO SCALE UP TB PREVENTION” in June 2021, calling on governments and other stakeholders to increase investment, expand the TB screening and diagnosis, and accelerate coverage of TB preventive treatment. To ensure reach the targets of TPT committed by Heads of State at the UN High Level Meeting on TB (UN-HLM) in 2018. The author systematically analyzed the current situation, the progress, the necessity and urgency of carrying out TPT in China, and put forward the countermeasures and suggestions of TPT in China.

Zhao Yanlin, Email: nc.defcdabcanihclyoahz
Copyright by Chinese Medical Association
No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.
引用本文

徐彩红,赵雁林. 全球加速扩展结核病预防性治疗行动计划背景下的中国对策[J]. 中华结核和呼吸杂志,2022,45(03)：308-312.

DOI:10.3760/cma.j.cn112147-20210722-00520

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价

版权归中华医学会所有。

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

2021年6月21日，世界卫生组织（World Health Organization，WHO）发布了全球加速扩展结核病预防性治疗的行动计划，即“Call to Action 2.0”，该倡议强调距离实现联合国高级别会议（UN High-level Meeting，UN-HLM）政治宣言承诺预防性治疗目标，即2018—2022年全球治疗3 000万结核潜伏感染（latent tuberculosis infection，LTBI）者的目标只剩下不到18个月的时间，WHO强烈要求各国政府和利益相关者积极行动，加速扩大结核病预防性治疗的覆盖面，履行UN-HLM政治宣言承诺的目标。全球结核病防治行动计划的发布，使我们不得不进一步强调预防性治疗的重要性和必要性，在有效的预防性疫苗到来之前，重新审视结核病预防性治疗的进程，并且认真思考如何快速推广预防性治疗的计划和举措。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Mack U , Migliori GB , Sester M ,et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement[J]. Eur Respir J, 2009,33(5):956-973. DOI: 10.1183/09031936.00120908 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Houben RM , Dodd PJ . The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling[J]. PLoS Med, 2016,13(10):e1002152. DOI: 10.1371/journal.pmed.1002152 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
World-Health Organization. Implementing the End TB Strategy: the essentials[M/OL]. Geneva:WHO, 2015[2021-07-17]. https://www.who.int/publications/i/item/9789241509930
返回引文位置Google Scholar
百度学术
万方数据
[4]
Zenner D , Beer N , Harris RJ ,et al. Treatment of latent tuberculosis infection: an updated network meta-analysis[J]. Ann Intern Med, 2017,167(4):248-255. DOI: 10.7326/M17-0609 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
World-Health Organization. The end TB strategy[M/OL]. Genava:WHO, 2014[2021-07-17]. https://www.who.int/publications/i/item/WHO-HTM-TB-2015.19
返回引文位置Google Scholar
百度学术
万方数据
[6]
Houben R , Menzies NA , Sumner T ,et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models[J]. Lancet Glob Health, 2016,4(11):e806-e815. DOI: 10.1016/S2214-109X(16)30199-1 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
World-Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment[M/OL]. Geneva:WHO, 2020[2021-07-17]:https://www.who.int/publications/i/item/9789240001503.
返回引文位置Google Scholar
百度学术
万方数据
[8]
World-Health Organization. UN General Assembly High-level Meeting on the fight against tuberculosis[R/OL]. New York:WHO, 2018[2021-07-17]. https://www.who.int/news-room/events/detail/2018/09/26/default-calendar/un-general-assembly-high--level-meeting-on-ending-tb.
返回引文位置Google Scholar
百度学术
万方数据
[9]
International-Union-Against-Tuberculosis Disease. Interventions For Tuberculosis Control and Elimination[M]. Paris:International Union Against Tuberculosis and Lung Disease, 2002.
返回引文位置
[10]
Menzies D , Al Jahdali H , Al Otaibi B . Recent developments in treatment of latent tuberculosis infection[J]. Indian J Med Res, 2011,133(3):257-266.
返回引文位置Google Scholar
百度学术
万方数据
[11]
A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council[J]. Am Rev Respir Dis, 1992,145(1):36-41. DOI: 10.1164/ajrccm/145.1.36 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Cruz AT , Starke JR . Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children[J]. Int J Tuberc Lung Dis, 2014,18(9):1057-1061. DOI: 10.5588/ijtld.14.0286 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Spyridis NP , Spyridis PG , Gelesme A ,et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study[J]. Clin Infect Dis, 2007,45(6):715-722. DOI: 10.1086/520983 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Haley CA , Stephan S , Vossel LF ,et al. Successful use of rifampicin for Hispanic foreign-born patients with latent tuberculosis infection[J]. Int J Tuberc Lung Dis, 2008,12(2):160-167.
返回引文位置Google Scholar
百度学术
万方数据
[15]
Galli L , Lancella L , Tersigni C ,et al. Pediatric tuberculosis in talian children: epidemiological and clinical data from the Italian register of pediatric tuberculosis[J]. Int J Mol Sci, 2016,17(6):960. DOI: 10.3390/ijms17060960 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Schechter M , Zajdenverg R , Falco G ,et al. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts[J]. Am J Respir Crit Care Med, 2006,173(8):922-926. DOI: 10.1164/rccm.200512-1953OC .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Martinson NA , Barnes GL , Moulton LH ,et al. New regimens to prevent tuberculosis in adults with HIV infection[J]. N Engl J Med, 2011,365(1):11-20. DOI: 10.1056/NEJMoa1005136 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
World-Health Organization. Latent TB Infection: Updated and consolidated guidelines for programmatic management[M/OL]. Geneva:WHO, 2018[2021-07-17]. https://www.who.int/publications/i/item/9789241550239.
返回引文位置Google Scholar
百度学术
万方数据
[19]
Swindells S , Ramchandani R , Gupta A ,et al. One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis[J]. N Engl J Med, 2019,380(11):1001-1011. DOI: 10.1056/NEJMoa1806808 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
World-Health Organization. Global tuberculosis report 2020[R/OL]. Geneva:WHO, 2020[2021-07-17]. https://www.who.int/publications/i/item/9789240013131.
返回引文位置Google Scholar
百度学术
万方数据
[21]
Gao L , Lu W , Bai L ,et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study[J]. Lancet Infect Dis, 2015,15(3):310-319. DOI: 10.1016/S1473-3099(14)71085-0 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
Gao L , Bai L , Liu J ,et al. Annual risk of tuberculosis infection in rural China: a population-based prospective study[J]. Eur Respir J, 2016,48(1):168-178. DOI: 10.1183/13993003.00235-2016 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Gao L , Li X , Liu J ,et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study[J]. Lancet Infect Dis, 2017,17(10):1053-1061. DOI: 10.1016/S1473-3099(17)30402-4 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Gao L , Zhang H , Xin H ,et al. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study[J]. Eur Respir J, 2018,52(6):1801470. DOI: 10.1183/13993003.01470-2018 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
Call to Action 2.0: A global drive to scale up TB prevention[R/OL]. Geneva:WHO, 2021[2021-07-17]. https://www.who.int/publications/m/item/call-to-action-2.0-a-global-drive-to-scale-up-tb-prevention.
返回引文位置
备注信息
A
赵雁林，Email： nc.defcdabcanihclyoahz
B

徐彩红, 赵雁林. 全球加速扩展结核病预防性治疗行动计划背景下的中国对策[J]. 中华结核和呼吸杂志, 2022, 45(3): 308-312. DOI: 10.3760/cma.j.cn112147-20210722-00520.

C
所有作者声明无利益冲突
D
“十三五”国家科技重大专项 (2017ZX10201302-001)
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
最新推荐
更多
罕见肺动脉肉瘤误诊1例
张建鑫
中国临床案例成果数据库 2024,06(01)
肺动脉肉瘤1例
荣春妍 等
中国临床案例成果数据库 2024,06(01)
双层探测器光谱CT对肺动脉肉瘤的诊断及与肺栓塞的鉴别一例
周宇涵 等
中国医师杂志 2023,25(01)
肺动脉肉瘤的诊断和外科治疗
甘辉立 等
中华医学杂志 2014,94(16)
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大